NCT00950794View on ClinicalTrials.gov

Study of Salmeterol (SN408D) for Adult Asthma

PHASE4CompletedINTERVENTIONAL

Enrollment

367

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions

AsthmaBronchial Asthma

Interventions

DRUG

Salmeterol(SN408D)

Salmeterol(SN408D)：long-acting Beta2-agonist

DRUG

Hokunalin (tulobuterol) tape

Hokunalin (tulobuterol) tape:long-acting Beta2-agonist

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY